SCHS Home Search FAQs Contacts
Navigation Bar

Projected New Cancer Cases and Deaths for Selected Sites by Sex
North Carolina, 2002

Primary Cancer SiteProjected New CasesProjected Deaths
TotalMaleFemaleTotalMaleFemale
Lip, Oral Cavity, Pharynx93062031040532085
     Tongue21014070957520
     Salivary Glands1005545302010
     Pharynx16512045503515
     Other Parts of Mouth45530515023019040
Digestive Organs, Peritoneum720538603540390520701835
     Esophagus38528510035527085
     Stomach675410265400235165
     Small Intestine1507575352015
     Colon, Rectum4435220022351735850885
     Liver, Bile Ducts430285145365225140
     Pancreas895430465850410440
     Other, Ill-defined sites43017525516560105
Respiratory System585533602495484029001940
     Larynx340265751159025
     Bronchus, Lung536029852375469027851905
     Other15511045352510
Bones and Joints754530402020
Soft Tissue including Heart2351251101206060
Malignant Melanoma of the Skin142579063522514085
Breast62454062051345101335
Genital Organs8675617525001770975795
     Cervix Uteri, Invasive395--395140--140
     Corpus Uteri1160--1160195--195
     Ovary775--775415--415
     Other Female Genital170--17045--45
     Prostate59055905--965965--
     Testis230230--55--
     Other Male Genital4040--55--
Urinary Organs26601830830705450255
     Urinary Bladder16751225450345230115
     Kidney, Renal Pelvis915560355345210135
     Other Urinary Organs70452515105
Eye and Orbit653530505
Brain, CNS550305245390215175
Endocrine Glands620170450653035
     Thyroid Gland570145425351520
     Other Endocrine Glands502525301515
Leukemia995560435620340280
     Lymphocytic Leukemia42525017517510075
     Myeloid Leukemia445240205275150125
     Monocytic Leukemia201010505
     Other Leukemia10560451659075
Lymphomas1795960835745390355
     Hodgkin's Disease220115105452520
     Non-Hodgkin's Lymphoma1575845730700365335
Multiple Myeloma450235215315160155
Miscellaneous11956405551105490615
ALL SITES3917019750194201660085708030

Includes all carcinomas of the urinary bladder, but excludes carcinoma in situ of all other sites and common skin cancer.

We believe the projections of new prostate cancer cases are higher than they should be. It is hard to project the number of new cases for this site because of the high incidence rates of the early 90's that resulted from the introduction of the PSA test.

Projected: An estimate of the cases, deaths, or disease rates that are expected tooccur in the future based on past experience.

Produced by the NC Central Cancer Registry,
State Center for Health Statistics, DHHS